Edesa Biotech Inc (NQ: EDSA )
4.630
-0.120
(-2.52%)
Streaming Delayed Price
Updated: 3:34 PM EDT, Jul 22, 2024
Add to My Watchlist
Press Releases about Edesa Biotech Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal Year 2022 Results
December 16, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech to Present at Upcoming H.C. Wainwright Investor Conference
September 08, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
September 07, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results
August 12, 2022
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech to Present at ARDS Drug Development Summit
July 11, 2022
From Edesa Biotech
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
From Edesa Biotech
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Appoints Strategy Expert to Board of Directors
March 29, 2022
From Edesa Biotech
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
From Edesa Biotech
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
February 17, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Fiscal 1st Quarter 2022 Results
February 14, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech to Join Ontario Bioscience Panel Discussion
January 26, 2022
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Reports Fiscal Year 2021 Results
December 28, 2021
From Edesa Biotech
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
December 01, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
Edesa Biotech Extends COVID-19 Clinical Study to Poland
November 04, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
September 20, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
September 09, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
August 13, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg)
Edesa Biotech Extends Dermatitis Study to Canada
July 13, 2021
From Edesa Biotech
Via AccessWire
Topics
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.